Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BIONTECH : Jefferies sticks Neutral

11/22/2021 | 02:29am EST

Initially Neutral on the company, Jefferies's analyst Akash Tewari maintained his recommendation. The target price remains unchanged at USD 230.


© MarketScreener with dpa-AFX Analyser 2021
All news about BIONTECH SE
01/25WALL STREET STOCK EXCHANGE : S&P ends down after another wild session
RE
01/25Pfizer starts clinical study on safety of Omicron-targeted vaccine
AQ
01/25Pfizer, BioNTech Launch Clinical Study of Omicron-Specific COVID-19 Vaccine
MT
01/25Pfizer, BioNTech start testing Omicron vaccine
RE
01/25BIONTECH : Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine i..
PU
01/25Pfizer begins study to test COVID-19 vaccine tweaked to fight Omicron variant
AQ
01/25BIONTECH : watchdogs' requirements may defer planned launch of Omicron shot
RE
01/25BioNTech, Google, Deutsche Bahn back African-founded AI firm
AQ
01/25Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine
RE
01/25Pfizer, BioNTech to Study Omicron-Based COVID-19 Vaccine in Adults
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 17 374 M 19 642 M 19 642 M
Net income 2021 9 220 M 10 423 M 10 423 M
Net cash 2021 8 824 M 9 976 M 9 976 M
P/E ratio 2021 3,79x
Yield 2021 -
Capitalization 33 442 M 37 796 M 37 806 M
EV / Sales 2021 1,42x
EV / Sales 2022 0,89x
Nbr of Employees 2 800
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 138,46 €
Average target price 257,15 €
Spread / Average Target 85,7%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE-39.30%37 796
GILEAD SCIENCES, INC.-5.56%86 013
REGENERON PHARMACEUTICALS-1.60%64 979
VERTEX PHARMACEUTICALS4.59%58 397
WUXI APPTEC CO., LTD.-7.49%51 604
BEIGENE, LTD.-8.15%25 568